A Clinical Pharmacology Study to Evaluate the Food Effect of JTT-751 in Patients with Iron Deficiency Anemia

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080223447

Enrollment

Registered

2017-01-30

Start date

2017-01-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron deficiency anemia

Interventions

investigational material(s) Generic name etc : Ferric Citrate Hydrate INN of investigational material : - Therapeutic category code : 322 Mineral preparations Dosage and Administration for Investigati

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Iron deficiency anemia -Hemoglobin level of = > 8.0 g/dL -BMI of = > 16.0 and < 25.0

Exclusion criteria

Exclusion criteria: - Anemia caused by othe than iron deficiency - Serum phosphate level of < 2.5mg/dL

Design outcomes

Primary

Measure	Time frame
pharmacokinetics Pharmacokinetics	—

Secondary

Measure	Time frame
safety Safety	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026